11 Aug 2026 (Navroze Bureau) : Artificial intelligence is increasingly being used in biological research, and scientists have demonstrated that AI can help design virus-like biological systems and viral proteins in laboratory settings.
While the development has attracted attention because of its potential applications in medicine and biotechnology, it also raises important questions about biosafety, oversight and responsible AI use in biology.
How AI Is Entering Virology
Researchers are using AI models to analyse biological data, predict protein structures and design new biological molecules.
These tools can accelerate research by helping scientists explore biological possibilities that would otherwise require extensive laboratory experimentation.
Potential Benefits for Medicine
AI-assisted biological design could eventually contribute to the development of vaccines, antiviral treatments and other medical technologies.
Scientists are particularly interested in using computational tools to understand how viruses interact with cells and how immune responses might be strengthened.
Why the Research Raises Concerns
The same technologies that can accelerate beneficial research could also create biosafety challenges if used irresponsibly.
For that reason, researchers and policymakers are increasingly discussing safeguards around AI-enabled biological design, laboratory controls and responsible access to sensitive capabilities.
AI Does Not Replace the Laboratory
Creating or designing a biological system is not simply a matter of asking an AI model to produce a virus.
Laboratory validation, specialised equipment, biological materials and extensive safety procedures remain necessary for experimental work.
A New Era of Biosecurity
The convergence of AI and biotechnology is likely to become an increasingly important area of scientific and regulatory debate.
The challenge will be to encourage legitimate medical research while ensuring that powerful biological-design technologies are developed and used under appropriate safeguards.